Drugmakers funnel payments to high-prescribing doctors

Drugmakers funnel payments to high-prescribing doctors

By Bob Herman  |  May 23, 2015

Nearly one-quarter of Medicare's top-prescribing physicians received consulting fees or other financial perks from manufacturers of the drugs they prescribed in 2013, renewing nagging questions about conflicts of interest in medical decisionmaking.

Appeals court orders Actavis to continue selling Alzheimer's drug

By Lisa Schencker  |  May 22, 2015

A federal appeals court ruled Friday that Actavis must continue to sell an Alzheimer's drug it wanted to pull off the market to limit competition from generics. It's a case with potential implications for pharmaceutical companies and patients nationwide, experts say.

Fewer kids have severe mental problems; more get help

By Associated Press  |  May 20, 2015

Contrary to public perception and horrific cases that make headlines, serious mental problems are declining among the nation's youth, and there has been a big rise in how many are getting help, a new study finds.

Johnson & Johnson expects lucrative return on drug pipeline

By Associated Press  |  May 20, 2015

Johnson & Johnson expects a lucrative return from its pharmaceutical business, with plans to seek approval by 2019 for more than 10 new products, each with the potential to top $1 billion in annual sales.

FDA's proposed antibiotic rule called tiny step toward combating superbugs

By Steven Ross Johnson  |  May 19, 2015

The Food and Drug Administration is seeking details from manufacturers of antimicrobials that are used in livestock. It's part of an effort to reduce development of antibiotic-resistant “superbugs” that make drugs used in both animals and humans no longer effective.

Study links antibiotic overuse to diagnostic mistakes

By Sabriya Rice  |  May 18, 2015

Diagnostic errors may be an overlooked factor in the battle to drive down the unnecessary use of antibiotics. In nearly every case where an initial diagnosis was undetermined or wrong, according to a new study, patients were given antibiotics they didn't need.

Stem cell 'Wild West' takes root amid lack of regulation

By Associated Press  |  May 18, 2015

The number of stem-cell clinics across the U.S. has surged from a handful in 2010 to more than 170 today. Many of the clinics are linked in large, for-profit chains. It's quackery, critics say. But it's also a mushrooming business—and almost wholly unregulated.

FDA issues safety alert on new class of Type 2 diabetes drug

By Sabriya Rice  |  May 15, 2015

The FDA is warning that a new class of Type 2 diabetes medications called sodium-glucose cotransporter-2 inhibitors may lead to a serious, potentially fatal condition in which the body overproduces a chemical called ketone and results in too much acid in the blood.

Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.